Osilodrostat

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 177 publications

Cushing's syndrome and pregnancy: Clinical presentation and diagnosis.

Cushing's syndrome and pregnancy: Clinical presentation and diagnosis.

Journal: Vitamins and hormones

Published: June 03, 2026

Correction to: "International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome".

Correction to: "International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome".

Journal: The Journal of clinical endocrinology and metabolism

Published: May 29, 2026

Ectopic ACTH-dependent Cushing syndrome in 3 hospitalized patients: lessons learned from management with osilodrostat.

Ectopic ACTH-dependent Cushing syndrome in 3 hospitalized patients: lessons learned from management with osilodrostat.

Journal: JCEM case reports

Published: May 25, 2026

Is Hypercortisolism Treatable? Which Patients Should Be Treated and How-A Practical Guide for Clinicians.

Is Hypercortisolism Treatable? Which Patients Should Be Treated and How-A Practical Guide for Clinicians.

Journal: Diabetes, obesity & metabolism

Published: May 20, 2026

Individualized osilodrostat treatment for patients with ACTH-dependent Cushing's syndrome: real-world evidence.

Individualized osilodrostat treatment for patients with ACTH-dependent Cushing's syndrome: real-world evidence.

Journal: Frontiers in endocrinology

Published: April 27, 2026

Severe Ectopic ACTH-Dependent Cushing Syndrome Due to a Neuroendocrine Tumor of Occult Primary Origin Presenting with Widespread Metastases and Early Vertebral Fractures: A Rare Case Report.

Severe Ectopic ACTH-Dependent Cushing Syndrome Due to a Neuroendocrine Tumor of Occult Primary Origin Presenting with Widespread Metastases and Early Vertebral Fractures: A Rare Case Report.

Journal: International medical case reports journal

Published: April 24, 2026

Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy.

Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy.

Journal: European journal of endocrinology

Published: April 23, 2026

Dose-Response Relationships and Comparative Efficacy of Aldosterone Synthase Inhibitors in Resistant Hypertension: A Comprehensive Network Meta-Analysis and Meta-Regression.

Dose-Response Relationships and Comparative Efficacy of Aldosterone Synthase Inhibitors in Resistant Hypertension: A Comprehensive Network Meta-Analysis and Meta-Regression.

Journal: Journal of clinical medicine

Published: April 04, 2026

Protracted osilodrostat-induced pan-adrenal steroidogenic suppression and adrenal size reduction in Cushing disease.

Protracted osilodrostat-induced pan-adrenal steroidogenic suppression and adrenal size reduction in Cushing disease.

Journal: JCEM case reports

Published: April 01, 2026

ACTH-dependent Cushing's syndrome in MEN1: When multiple tumors complicate the diagnosis.

ACTH-dependent Cushing's syndrome in MEN1: When multiple tumors complicate the diagnosis.

Journal: Annales d'endocrinologie

Published: February 27, 2026

Osilodrostat for the treatment of Cushing syndrome: an update.

Osilodrostat for the treatment of Cushing syndrome: an update.

Journal: Expert review of endocrinology & metabolism

Published: February 20, 2026

More on Osilodrostat for Bilateral Adrenal Hypercortisolism in Primary Aldosteronism.

More on Osilodrostat for Bilateral Adrenal Hypercortisolism in Primary Aldosteronism.

Journal: The New England journal of medicine

Published: February 18, 2026

Showing 1-12 of 177

Last Updated: 09/26/2026